Singlera Genomics: Funding, Investors & Team (Oct 2026)
Singlera Genomics is a quickly developing organization zeroing in on painless hereditary testing. Singlera's principal items and administrations incorporate growth conclusion and customized treatment, harmless pre-birth finding, pre-implantation hereditary screening, and tweaked logical exploration administrations. Singlera is committed to the advancement of accuracy medication, endeavoring to help the patients through right on time, exact and instructive determinations.
Singlera Genomics has raised $44.9M across 1 funding round on record, the most recent a Series B of $44.9M announced in Jun 2022.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Singlera Genomics Company Profile and Key Stats
Latest funding round on record: Jun 2022.
Singlera Genomics Funding Rounds
Singlera Genomics Founders and Leadership Team
Contact details for the Singlera Genomics team: 1 of 1 has an email address on file.
Start 14-day free trial →Singlera Genomics Funding Compared to Other Biotechnology Startups
Singlera Genomics' latest round of $44.9M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Singlera Genomics in Biotechnology and La Jolla
Companies Similar to Singlera Genomics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Singlera Genomics Funding FAQs
What does Singlera Genomics do?
Singlera Genomics is a quickly developing organization zeroing in on painless hereditary testing. Singlera's principal items and administrations incorporate growth conclusion and customized treatment, harmless pre-birth finding, pre-implantation hereditary screening, and tweaked logical exploration administrations. Singlera is committed to the advancement of accuracy medication, endeavoring to help the patients through right on time, exact and instructive determinations.
How much funding has Singlera Genomics raised?
Singlera Genomics has raised $44.9M across 1 round on record. The most recent is a Series B of $44.9M announced in Jun 2022.
When did Singlera Genomics last raise funding?
Singlera Genomics' most recent funding round on record is a Series B of $44.9M, announced in Jun 2022.
Who founded Singlera Genomics?
FundedIQ lists Qiang Liu (Founder) at Singlera Genomics.
Where is Singlera Genomics headquartered?
Singlera Genomics is based in La Jolla, California, United States.
How many employees does Singlera Genomics have?
Singlera Genomics is in the 11-50 employee band.
How does Singlera Genomics' funding compare to other Biotechnology startups?
Singlera Genomics' latest round of $44.9M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Singlera Genomics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Singlera Genomics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.